Bromide

Bromide

SCHEMBL970792

Br.Br.O.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7119680 1.00
Bromide SCHEMBL1945233 1.00
Bromide SCHEMBL1403762 1.00
Bromide SCHEMBL9345034 1.00
Bromide SCHEMBL7434275 1.00
Bromide SCHEMBL7402625 1.00 CA1 (0.50)
Bromide SCHEMBL11273331 1.00
Bromide SCHEMBL4237775 1.00
Bromide SCHEMBL8143980 1.00
Bromide SCHEMBL2303098 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1961751-B1 ACID ADDITION SALT OF OPTICALLY ACTIVE DIHYDROPYRIDINE DERIVATIVE UBE INDUSTRIES (JP) 2012-11-21 EP claimed
JP-61215396-A None JP disclosed
US-20230272449-A1 IDENTIFICATION OF INHIBITORS OF TCPC AND TIR NADase ACTIVITY WASHINGTON UNIVERSITY 2023-08-31 US disclosed
US-20200283820-A1 IDENTIFICATION OF INHIBITORS OF TCPC AND TIR NADase ACTIVITY WASHINGTON UNIVERSITY 2020-09-10 US disclosed
US-20190298841-A1 Nucleic Acid Complexes PROCARTA BIOSYSTEMS LTD (GB) 2019-10-03 US disclosed
CN-110300624-A Cupric MOZ zeolite for selective N Ox reduction catalysts 优美科股份公司及两合公司 2019-10-01 CN disclosed
US-10350299-B2 Nucleic acid complexes PROCARTA BIOSYSTEMS LTD. (GB) 2019-07-16 US disclosed
WO-2019067625-A1 IDENTIFICATION OF INHIBITORS OF TCPC AND TIR NADASE ACTIVITY WASHINGTON UNIVERSITY (US) 2019-04-04 WO disclosed
CN-105705610-B Compound with end heteroaryl cyano group ethenylidene and its application in organic solar batteries 巴斯夫欧洲公司 2018-01-30 CN disclosed
US-20170340745-A1 NUCLEIC ACID COMPLEXES PROCARTA BIOSYSTEMS LTD. (GB) 2017-11-30 US disclosed
US-20100305326-A1 Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage MARQUETTE UNIVERSITY (US) 2010-12-02 US disclosed
US-20100304998-A1 Chemical Proteomic Assay for Optimizing Drug Binding to Target Proteins MARQUETTE UNIVERSITY (US) 2010-12-02 US disclosed
EP-1674444-A1 METHOD FOR PRODUCING ESTER CONDENSED PRODUCT Japan Science and Technology Agency (JP) 2006-06-28 EP disclosed
WO-1997048705-A1 POTASSIUM CHANNEL BLOCKERS UNIVERSITY COLLEGE LONDON (GB) 1997-12-24 WO disclosed
EP-0543001-A1 USE OF ANTIARRHYTHMIC AGENTS TO LOWER CHOLESTEROL THE UNIVERSITY OF ROCHESTER (US) 1993-05-26 EP disclosed
WO-1992022299-A2 USE OF ANTIARRHYTHMIC AGENTS TO LOWER CHOLESTEROL UNIVERSITY OF ROCHESTER (US) 1992-12-23 WO disclosed
US-5166142-A Anticholesterol agents such as quinidine, procainamide or disopyramide UNIVERSITY OF ROCHESTER (US) 1992-11-24 US disclosed
EP-0188361-B1 AMINE DERIVATIVES GLAXO GROUP LIMITED (GB) 1991-03-06 EP disclosed
JP-S61215396-A 7-AMINO-3-PYRIDINIUM METHYL-CEPHEM DERIVATIVE DAI ICHI SEIYAKU CO LTD 1986-09-25 JP disclosed
US-4238611-A Polysubstituted derivatives of 10-piperazinodibenzo (b,f) thiepine SPOFA, UNITED PHARMACEUTICAL WORKS (CS) 1980-12-09 US disclosed